1 unknown. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Unknown 1 |
Follow Birth Defect: new trials by email Literature Review of Birth Defect trials Research Report on Birth Defect
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical Transmission Tenofovir Disoproxil Fumarate (TDF) 300 mg oral daily. - Hepatitis B Infection, Congenital Malformation | Phase 4 | Unknown | New Discovery LLC | 280 | 2018-06-10 | 2019-12-12 |
Congenital Abnormalities (1) · Hepatitis B (1) · Persistent Infection (1) · Viremia (1)
Blood-Borne Infections (1) · Communicable Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · DNA Virus Infections (1) · Digestive System Diseases (1) · Disease Attributes (1) · Hepadnaviridae Infections (1) · Hepatitis (1) · Hepatitis, Viral, Human (1) · Infections (1) · Inflammation (1) · Liver Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Sepsis (1)
Tenofovir (1) · hepatitis B hyperimmune globulin (1)
China (1)
Calvin Q Pan, MD (1) · Erhei Dai, MD (1)